Kawai M, Minabe Y, Takagai S, Ogai M, Matsumoto H, Mori N, Takei N. Poor
maternal care and high maternal body mass index in pregnancy as a risk
factor for schizophrenia in offspring. Acta Psychiat Scand 110: 257-263,
2004.
SekizawaT, Iwata Y, Nakamura K, Matsumoto H, Suzuki A, Minabe Y, Mori N.
Childhood-onset schizophrenia and tryptophan hydroxylase gene polymorphism
Am J Med Genet 128B: 24-26, 2004.
Suzuki K, Takei N, Sekine Y, Tani K, Toyoda T, Ohashi Y, Kawai M, Hoshino R, Iyo M, Mori N. Do Jiko-shu-kyofu (a subtype of Taijin-kyofu) and olfactory reference syndrome share a common entity?
Acta Psychiar Scand 109: 150-155, 2004.
Takebayashi K, Sekine Y, Takei N, Minabe Y, Isoda H, Takeda H, Nishimura K, Nakamura K, Suzuki K, Iwata Y, Sakahara H, Mori N.
Metabolite alterations in basal ganglia associated with psychiatric symptoms
of abstinent toluene users: a proton MRS study. Neuropsychopharmacol 29:
1019-1026, 2004.
Takei N, Nakamura K: Is inseki-jisatsu, responsibility-driven suicide,
a culture-bound form of suicide? Lancet 363: 1400, 2004.
Tani K, Takei N, Kawai M, Suzuki K, Sekine Y, Minabe Y, Mori N. Augmentation of milnacipran by risperidone in treatment for major depression.
Int J Neuropsychopharmacol 7: 55-58, 2004.
Tsuchiya KJ, Takei N.
Focus on psychiatry in Japan.
Br J Psychiatr 184: 88-92, 2004.
Tsuchiya KJ, Agerbo E, Byrne M, Mortensen PB.
Higher socio-economic status of parents may increase risk for bipolar disorder
in the offspring.
Psychol Med 34: 787-793, 2004.
Yamada K#, Nakamura K#, Minabe Y# (#equally contributed to this work),
Shigeno Y, Takao H, Toyota T, Hattori E, Takei N, Sekine Y, Suzuki K, Iwata
Y, Miyoshi K, Honda A, Baba K, Katayama T, Tohyama M, Mori N, Yoshikawa
T.
Association of FEZ1 gene variants including Asp123Glu with schizophrenia subset in Japan.
Biol Psychiatry 56: 683-690, 2004.
Yokoshima T, Takei N, Tani K, Kawai M, Minabe Y, Mori N.
Two cases of perospirone-induced mania in schizophrenia.
J Clin Psychiatry 65: 135, 2004.
Harano M, Uchimura N, Abe H, Ishibashi M, Iida N, Yanagimoto K, Tanaka
T, Maeda H, Sora I, Iyo M, Komiyama T, Yamada M, Sekine Y, Inada T, Ozaki
N, Ujike H.
A polymorphism of DRD2 gene and brain atrophy in methamphetamine psychosis.
Ann NY Acad Sci 1025: 307-315, 2004
Ide M, Muratake T, Yamada K, Iwayama-Shigeno Y, Iwamoto K, Takao H, Toyota T, Kaneko N, Minabe Y, Nakamura K, Kato T, Mori N, Asada T, Someya T, Yoshikawa T.
Genetic and expression analyses of FDZ3 in schizophrenia.
Biol Psychiatry 56: 462-465, 2004.
Ide S, Kobayashi H, Tanaka K, Ujike H, Sekine Y, Ozaki N, Inada T, Harano
M, Komiyama T, Yamada M, Iyo M, Ikeda K, Sora I.
Gene polymorphisms of the mu opioid receptor in methamphetamine abusers.
Ann NY Acad Sci 1025: 316-324, 2004.
Inada T, Iijima Y, Uchida N, Maeda T, Iwashita S, Ozaki N, Harano M, Komiyama
T, Yamada M, Sekine Y, Iyo M, Sora I, Ujike H.
No association found between the type 1 sigma receptor gene polymorphisms and methamphetamine abuse in the Japanese population: a collaborative study by the Japanese genetic initiative for drug abuse.
Ann NY Acad Sci 1025: 27-33, 2004.
Iwata N, Inada T, Harano M, Komiyama T, Yamada M, Sekine Y, Iyo M, Sora
I, Ujike H, Ozaki N.
No association is found between the candidate genes of t-PA/plasminogen system and Japanese methamphetamine-related disorder: a collaborative study by the Japanese genetic initiative for drug abuse.
Ann NY Acad Sci 1025:34-38, 2004.
Iyo M, Sekine Y, Mori N.
Neuromechanism of developing methamphetamine psychosis: a neuroimaging study.
Ann NY Acad Sci 1025: 288-295, 2004.
Kelly BD, Feeney L, Browne R, Byrne M, Mulryyan N, Scully A, Morris M,
Kinesella A, Takei N, McNeil T, Walsh D, Larkin C, O’Callaghan E.
Obstetric adversity and age at the first presentation in schizophrenia: evidence of a casual relationship.
Am J Psychatr 161: 920-2, 2004.
Kockelkorn TT, Arai M, Matsumoto H, Fukuda N, Yamada K, Minabe Y, Toyota T, Ujike H, Sora I, Mori N, Yoshikawa T, Itokawa M.
Association study of polymorphisms in the 5' upstream region of human DISC1 gene with schizophrenia.
Neurosci Lett 368: 41-5, 2004.
Koizumi H, Hashimoto K, Kumakiri C, Shimizu E, Sekine Y, Ozaki N, Inada
T, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Takei N, Iyo M.
Association between the glutathione S-transferase M1 gene deletion and
female methamphetamine abusers.
Am J Med Genet 126B: 43-45, 2004.
Kobayashi H, Ide S, Hasegawa J, Ujike H, Sekine Y, Ozaki N, Inada T, Harano
M, Komiyama T, Yamada M, Iyo M, Shen HW, Ikeda K, Sora I.
Study of association alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence.
Ann NY Acad Sci 1025: 325-334, 2004.
Matsuura M, Adachi N, Oana Y, Okubo Y, Kato M, Nakano T, Takei N.
A polydiagnostic and dimensional comparison of epileptic psychoses and schizophrenia sepctrum disorders.
Schizophr Res 69: 189-201, 2004.
Matsuzaki H, Namikawa K, Kiyama H, Mori N, Sato K.
Brain-derived neurotrophic factor rescues neuronal death induced by
methamphetamine.
Biol Psychiatry 55: 52-60, 2004.
Shirayama Y, Takahashi S, Minabe Y, Ogino T.
1H NMR spectroscopy show an increase in the NAAG and glutamate contents
in the hippocampus of amygdaloid kindled rat.
J Neurochem 92: 1317-1326, 2004.
Toyota T, Yoshitsugu K, Ebihara M, Yamada K, Ohba H, Fukasawa M, Minabe Y, Nakamura K, Sekine Y, Takei N, Suzuki K, Itokawa M, Meerabux JM, Iwayama-Shigeno Y, Tomaru Y, Shimizu H, Hattori E, Mori N, Yoshikawa T.
Association between schizophrenia with ocular misalignment and polyalanine
length variation in PMX2B.
Hum Mol Genet 13: 551-561, 2004.
|
主な研究とプロジェクト
